Literature DB >> 12725125

The androgen receptor CAG repeat and prostate cancer risk.

Peter E Clark1, Ryan A Irvine, Gerhard A Coetzee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12725125     DOI： 10.1385/1-59259-372-0:255

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  7 in total

Review 1.  Dependence receptors: between life and death.

Authors:  P Mehlen; C Thibert
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

2.  Influence of androgen receptor repeat polymorphisms on personality traits in men.

Authors:  Lars Westberg; Susanne Henningsson; Mikael Landén; Kristina Annerbrink; Jonas Melke; Staffan Nilsson; Roland Rosmond; Göran Holm; Henrik Anckarsäter; Elias Eriksson
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

Review 3.  Polyglutamine androgen receptor-mediated neuromuscular disease.

Authors:  Elisa Giorgetti; Andrew P Lieberman
Journal:  Cell Mol Life Sci       Date:  2016-05-17       Impact factor: 9.261

Review 4.  Sex steroid-related candidate genes in psychiatric disorders.

Authors:  Lars Westberg; Elias Eriksson
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

5.  ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract.

Authors:  Xiaomeng Li; Chunfang Zhu; William H Tu; Nanyang Yang; Hui Qin; Zijie Sun
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

6.  Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study.

Authors:  Kainan Li; Chen Zhong; Jun Wang; Baocheng Wang; Jun He; Jingwang Bi
Journal:  Tumour Biol       Date:  2014-09-14

7.  Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.

Authors:  Yongfeng He; Jiaqi Mi; Adam Olson; Joseph Aldahl; Erika Hooker; Eun-Jeong Yu; Vien Le; Dong-Hoon Lee; Won Kyung Kim; Diane M Robins; Joseph Geradts; Zijie Sun
Journal:  Oncogene       Date:  2020-02-24       Impact factor: 9.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.